Lammering. Inhibition of the Type III Epidermal Growth Factor Receptor Variant Mutant Receptor by Dominant-negative EGFR-CD533 Enhances Malignant Glioma Cell Radiosensitivity. no. 19, American Association for Cancer Research (AACR), Oct. 2004, doi:10.1158/1078-0432.ccr-04-0393.